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Clinical evaluation of preoperative pathological examinations for 
the diagnosis of lung cancer
Zhouyuan, Zhouyuan Z.; Wangdong, Wangdong 
The 81st Hospital of PLA, Nanjing, China
Objective: To investigate the way and its clinical value of preoperative 
pathological examinations in the pathological diagnosis of lung cancer. 
Methods: From Jan.2000 to Jan.2005, 585 patients of primary lung 
cancer were treated surgically in our hospital. Their clinical and patho-
logical records were reviewed. 
Results: Of 585 patients, 529 cases(90.4%) were pathologically 
diagnosed before operation. The positive rate of sputum collection 
for examining exfoliated cells was 24.3%(68/280). The positive 
rates of bronchoﬁbroscopy(BF) and percutaneous aspiration lung 
biopsy(PALB) were 56.7%(267/471) and 91.5%(238/260) respectively. 
Conclusions: BF and PALB are the main approaches for the preopera-
tive pathological diagnosis of lung cancer. PALB is a safe and effective 
means to improve the pathological diagnostic accuracy of peripheral 
lung cancer.
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Awareness of smoking among hospital workers
Bando, Hiroyasu 
Tokushima Prefectural Chuo Hospital, Tokushima, Japan
Since April 2005, smoking has been prohibited in all Tokushima 
Prefectural Kaifu Hospital buildings. We investigated awareness of 
smoking among all hospital workers in October 2006 with the aim of 
imposing a complete prohibition on smoking on hospital property in 
the future.
The survey was conducted on 139 hospital workers (38 males, 101 
females), all of whom responded. The subjects included nine medical 
staff (medical ofﬁce), 40 clerical staff (management department), 65 
nursing staff (nursing department) and 25 co-medicals. Their age dis-
tribution was as follows: ≤30 years (27%), 31≤40 years (22%), 41≤50 
years (24%), 51≤60 years (25%) and ≥61 years (3%).
The smoking rate was 11.5%, which was lower than the data obtained 
in Tokushima Prefectural Chuo Hospital in 1995 (15.3%) and 2001 
(13.6%). The smoking rate by occupation was as follows: medical staff 
(22%), clerical staff (13%), nursing staff (6%) and co-medicals (20%). 
The smoking cessation rate (the percentage of those with a past history 
of smoking) was 11.5%.
Sixteen smokers were asked about what measures they would take in 
the event of a total ban on smoking on hospital property. No smokers 
(0%) answered: “I cannot endure a total ban on smoking.” The percent-
age of respondents who said: “I don’t need anywhere to smoke” was 
high at 75%, with only 25% saying, “I want a smoking area outside of 
hospital property (boundary).” When the same questions were asked in 
a survey in Tokushima Prefectural Chuo Hospital in 2001, the percent-
ages for the above three options were 14%, 55% and 31% respectively. 
Compared with that data, the results of the current survey showed 
improved awareness about smoking.
In line with these results, a total ban on smoking on hospital property is 
to be enforced from May 31, 2007 (World No Tobacco Day).
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Cohort KBP-2000-CPHG: Survival in primary bronchial cancer at 
5 years
Blanchon, François1 Grivaux, Michel1 Zureick, M.2 Asselain, B.3 
Breton, Jean Luc4 Pichon, E.5 Bernabeu, L.6 Dournovo, P.7 Fournier, E.8 
Lauwenier, C.9 
1 Centre Hospitalier de Meaux, Meaux, France 2 INSERM, Paris, 
France 3 Institut CURIE, Paris, France 4 Centre Hospitalier de 
Belfort, Belfort, France 5 Centre Hospitalier de Blois, Blois, France 6 
Centre Hospitalier de Chauny, Chauny, France 7 Centre Hospitalier 
d’Eaubonne, Eaubonne, France 8 Centre Hospitalier d’Henin Beau-
mont, Henin Beaumont, France 9 Centre Hospitalier de Saint Omer, 
Saint Omer, France 
Objectives: Primary Bronchial Cancer(PBC)has a guarded progno-
sis despite advances in treatment. The main epidemiologic changes 
observed during the last ﬁfteen years are the strong progression in its 
incidence in women and the increase in adenocarcinomas. A prospec-
tive study of overall survival at 5 years was set up from the cohort 
KBP-2000-CPHG(CPHG: College of General Hospital-based Pneu-
mologists).
Materials and Methods: KBP-2000-CPHG is a prospective epide-
miological study conducted throughout the year 2000 on histologically 
conﬁrmed PBC patients treated in general hospitals. 5667 patients were 
included. A survival study based on patient outcomes was launched 
between September 2005 and December 2005 in the 137 centres. Each 
centre had to provide information on the vital status of its patients with, 
in the event of death, the date and cause. In the absence of vital status 
data, a graduated tracing strategy was set up including the interrogation 
of various ﬁles: town hall of the place of birth, etc.
Results: 135 investigator centres out of the 137 initial centres took 
part. The two non-participating centres represented 56 patients. The vi-
tal status could be deﬁned for 5447 of the other 5667 patients(97.1%). 
89.6% of these patients had died (average time between inclusion and 
death: 11.0-11.6 months) at 5 years. Median follow-up for survivors 
was 57.3+or-8.7 months. For the patients alive at 5 years(n=567, 
10.4%), the survival is 3.8% for small-cell lung cancer(SCLC) and 
11.8% for non small cell cancer(NSCLC).
In univariate study, survival status is linked with age(p<0,0001), tobac-
co consumption (p<0,0001), performans status (p<0,0001), histologi-
cal diagnosis (SCLC versus NSCLC;p<0,0001) and for the NSCLC, 
with histological type (% of dead: squamous cell carcinoma 86.3%; 
adenocarcinoma 89.7%; large cell carcinoma 92.8%; broncho-alveolar 
carcinoma 87.2%; p<0,0001) and TNM stage(p<0,0001).
According to multivariate analysis among the NSCLC, survival 
status is related to age, sex, performans status, histological type(large 
cell;p=0.002) and TNM stage.
Conclusion: This survival study on PBC is the ﬁrst one in France, 
including more than 5400 patients. The results show the prognosis role 
of age, sex,histological type, performans status and TNM stage.
